1. Home
  2. NUWE vs SPRC Comparison

NUWE vs SPRC Comparison

Compare NUWE & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

N/A

Current Price

$5.45

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

N/A

Current Price

$0.60

Market Cap

2.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUWE
SPRC
Founded
1999
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.7M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
NUWE
SPRC
Price
$5.45
$0.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
★ 1.9M
Earning Date
11-11-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $8,270,000.00
N/A
Revenue This Year
$19.32
$7,708.85
Revenue Next Year
$12.01
$73.22
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.28
$0.46
52 Week High
$222.30
$15.79

Technical Indicators

Market Signals
Indicator
NUWE
SPRC
Relative Strength Index (RSI) 48.48 16.59
Support Level $3.85 $0.52
Resistance Level $13.14 $5.46
Average True Range (ATR) 0.81 0.47
MACD 0.47 -0.10
Stochastic Oscillator 78.02 0.28

Price Performance

Historical Comparison
NUWE
SPRC

About NUWE Nuwellis Inc.

Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: